Close Menu

NEW YORK – A group of researchers at Spain's University of Zaragoza have applied a novel heat-based method called "thermal liquid biopsy" to establish a risk score that they said could predict the presence of and monitor lung cancer in a patient's bloodstream. 

The team envisions applying the minimally invasive technology and a predictive risk score to complement standard imaging techniques to screen for a variety of cancers in the clinical space. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.